Batir Daminov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Batir Daminov has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Olimkhon Sharapov
Department of Adult and Pediatric Nephrology, Republican Specialized Scientific Practical Medical Center of Nephrology and Kidney Transplantation, Tashkent, Uzbekistan
1 shared publication - Ranokhon Igamberdieva
Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan
1 shared publication - Sherzod Abdullaev
Republican Specialized Scientific and Practical Medical Center for Nephrology and Kidney Transplantation, Tashkent State Medical University, Tashkent, Uzbekistan
1 shared publication
Latest Publications
- Open Access
- 2 April 2021
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 10 (3) , e17
Epidemiological, clinical and morphological aspects of kidney damage in COVID-19
The mini-review presents modern data on the epidemiology, clinical and morphological aspects of kidney damage in COVID-19. Potential mechanisms of kidney involvement in the clinical picture of the disease may include cytokine damage, cross-organ damage, and systemic effects that determine the treatment strategy. These mechanisms are closely interrelated and are especially important for individuals undergoing extracorporeal therapy and kidney transplants. Autopsy data provide evidence of SARS-CoV-2 virus invasion into kidney tissue with damage to tubular epithelial cells and podocytes, and erythrocyte aggregation in persons with severe COVID-19. By including people with chronic kidney disease in planned COVID-19 research protocols, an evidence base for effective and safe treatments can be generated.
- 2 April 2021
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 10 (3) , e17
Open AccessEpidemiological, clinical and morphological aspects of kidney damage in COVID-19
The mini-review presents modern data on the epidemiology, clinical and morphological aspects of kidney damage in COVID-19. Potential mechanisms of kidney involvement in the clinical picture of the disease may include cytokine damage, cross-organ damage, and systemic effects that determine the treatment strategy. These mechanisms are closely interrelated and are especially important for individuals undergoing extracorporeal therapy and kidney transplants. Autopsy data provide evidence of SARS-CoV-2 virus invasion into kidney tissue with damage to tubular epithelial cells and podocytes, and erythrocyte aggregation in persons with severe COVID-19. By including people with chronic kidney disease in planned COVID-19 research protocols, an evidence base for effective and safe treatments can be generated.